Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Catalent
Podcast
Advancements in cell & gene therapy manufacturing (Part II)
This week’s episode of “The Top Line” is the second part of a series exploring the latest advancements in cell and gene therapy manufacturing.
Ayla Ellison
,
Fraiser Kansteiner
May 17, 2024 8:58am
FTC to review Novo Holdings' Catalent buyout for another month
May 3, 2024 2:00pm
Novo Nordisk scales Wegovy supply amid pressure from Lilly
May 2, 2024 11:56am
FTC to review Novo Holdings' Catalent buyout for 30 more days
Apr 8, 2024 11:58am
Catalent conducting fresh round of layoffs in Indiana
Mar 21, 2024 12:27pm
Catalent reorg leaves 300 without jobs as CDMO awaits buyout
Feb 15, 2024 8:45am